Diane Damotte

Author PubWeight™ 68.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005 12.64
2 Prognostic significance of vascular and lymphatic emboli in resected pulmonary adenocarcinoma. Ann Thorac Surg 2013 2.63
3 Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis. J Thorac Cardiovasc Surg 2012 2.57
4 Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2008 2.39
5 Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J Clin Invest 2010 2.02
6 Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res 2011 1.91
7 Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res 2011 1.63
8 Pneumothorax recurrence after surgery in women: clinicopathologic characteristics and management. Ann Thorac Surg 2011 1.58
9 Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors. PLoS One 2011 1.55
10 Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res 2013 1.54
11 Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004 1.48
12 Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Rep 2012 1.45
13 Study of the impact of liver transplantation on the outcome of intestinal grafts in children. Transplantation 2006 1.44
14 Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med 2014 1.39
15 Reply to the editor. J Thorac Cardiovasc Surg 2013 1.39
16 Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clin Cancer Res 2013 1.33
17 Immune infiltration in human cancer: prognostic significance and disease control. Curr Top Microbiol Immunol 2011 1.32
18 Tumor microenvironment is multifaceted. Cancer Metastasis Rev 2011 1.28
19 Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest 2012 1.27
20 Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J Immunol 2004 1.24
21 Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. Circ Res 2011 1.17
22 Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases. Proc Natl Acad Sci U S A 2003 1.14
23 The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort. Chest 2014 1.13
24 Pneumothorax in women of child-bearing age: an update classification based on clinical and pathologic findings. Chest 2014 1.03
25 The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. Am J Respir Crit Care Med 2015 1.02
26 The immune microenvironment of human tumors: general significance and clinical impact. Cancer Microenviron 2012 0.98
27 Immunoregulatory pathways controlling progression of autoimmunity in NOD mice. Ann N Y Acad Sci 2008 0.98
28 Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer. J Thorac Cardiovasc Surg 2011 0.97
29 Front-line high-dose chemotherapy with rituximab showed excellent long-term survival in adults with aggressive large b-cell lymphoma: final results of a Phase II GOELAMS Study. Biol Blood Marrow Transplant 2010 0.97
30 A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation. Eur J Immunol 2011 0.92
31 The Pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis. J Immunol 2007 0.91
32 An interval tightly linked to but distinct from the H2 complex controls both overt diabetes (Idd16) and chronic experimental autoimmune thyroiditis (Ceat1) in nonobese diabetic mice. Diabetes 2002 0.88
33 Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience. Eur J Cardiothorac Surg 2012 0.87
34 Autoimmunity during thymectomy-induced lymphopenia: role of thymus ablation and initial effector T cell activation timing in nonobese diabetic mice. J Immunol 2009 0.86
35 Intratumoral distribution of EGFR mutations and copy number in metastatic lung cancer, what impact on the initial molecular diagnosis? J Transl Med 2014 0.85
36 Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Valpha14-NKT cell performance but failure to protect against type 1 diabetes. Diabetes 2006 0.85
37 Composite mantle cell and follicular lymphoma. A case report. Hum Pathol 2008 0.81
38 [Human lung cancer: role of TLR7 and TLR8 in cell survival and chemoresistance]. Med Sci (Paris) 2010 0.80
39 Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J Immunol 2002 0.80
40 Ginger prevents Th2-mediated immune responses in a mouse model of airway inflammation. Int Immunopharmacol 2008 0.80
41 Necrotizing pneumonia in adults: multidisciplinary management. Intensive Care Med 2011 0.78
42 Comparison of coronal and axial computed tomography measurements of mediastinal nodes before primary surgery for non-small cell lung cancer. Eur J Radiol 2011 0.78
43 Fas ligand-mediated lethal hepatitis after rapid lysis of a localized natural killer cell lymphoma. Clin Lymphoma Myeloma 2006 0.78
44 Alternatives to resectional surgery for infectious disease of the lung: from embolization to thoracoplasty. Thorac Surg Clin 2012 0.78
45 IL-10 is necessary for FasL-induced protection from experimental autoimmune thyroiditis but not for FasL-induced immune deviation. Eur J Immunol 2002 0.77
46 T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy? Hum Pathol 2007 0.77
47 Homocysteine is not detected in normal human vessel walls. Atherosclerosis 2005 0.77
48 The immune microenvironments of lung and intraocular tumors. Bull Cancer 2011 0.77
49 Efficiency of hydroxychloroquine in the treatment of granulomatous complications in chronic granulomatous disease. Eur J Gastroenterol Hepatol 2008 0.76
50 Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor. Blood 2008 0.76
51 Prognostic value of LIPC in non-small cell lung carcinoma. Cell Cycle 2013 0.75
52 High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study. Br J Haematol 2013 0.75
53 [Hematologic pathology and immunodepression outside of HIV infection: modification of the histopathologic semiology]. Ann Pathol 2008 0.75
54 Atypical skin lesions revealing an EBV-associated hemophagocytic syndrome after a large B cell lymphoma in complete remission. Leuk Lymphoma 2007 0.75
55 A steroid-refractory ulcerative colitis revealing Epstein-Barr virus/cytomegalovirus-positive colonic lymphoma. Int J Colorectal Dis 2005 0.75
56 [A disconcerting pleural effusion]. Ann Pathol 2009 0.75
57 CD4+CD25+ T cells play a complex role in the pediatric combined liver-intestinal graft acceptance. Transplantation 2010 0.75